Correlation Between Nkarta and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nkarta and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Entrada Therapeutics, you can compare the effects of market volatilities on Nkarta and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Entrada Therapeutics.
Diversification Opportunities for Nkarta and Entrada Therapeutics
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Nkarta and Entrada is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Nkarta i.e., Nkarta and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Nkarta and Entrada Therapeutics
Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Entrada Therapeutics. In addition to that, Nkarta is 2.02 times more volatile than Entrada Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.28 per unit of volatility. If you would invest 1,714 in Entrada Therapeutics on September 1, 2024 and sell it today you would earn a total of 275.00 from holding Entrada Therapeutics or generate 16.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nkarta Inc vs. Entrada Therapeutics
Performance |
| Timeline |
| Nkarta Inc |
| Entrada Therapeutics |
Nkarta and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nkarta and Entrada Therapeutics
The main advantage of trading using opposite Nkarta and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Nkarta vs. Monte Rosa Therapeutics | Nkarta vs. Lyell Immunopharma | Nkarta vs. Generation Bio Co | Nkarta vs. Sana Biotechnology |
| Entrada Therapeutics vs. Molecular Partners AG | Entrada Therapeutics vs. Pmv Pharmaceuticals | Entrada Therapeutics vs. Monte Rosa Therapeutics | Entrada Therapeutics vs. Vigil Neuroscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |